SMSPHARMAPharmaceuticals
Sms Pharmaceuticals Ltd — Balance Sheet
₹374.85
-5.18%
Sms Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 8.87 Cr | 8.47 Cr | 8.47 Cr | 8.47 Cr | — |
| Share Issued | 8.87 Cr | 8.47 Cr | 8.47 Cr | 8.47 Cr | — |
| Net Debt | 269.36 Cr | 244.14 Cr | 245.21 Cr | 213.53 Cr | — |
| Total Debt | 310.76 Cr | 280.77 Cr | 254.07 Cr | 263.27 Cr | — |
| Tangible Book Value | 637.51 Cr | 533.67 Cr | 459.06 Cr | 468.92 Cr | — |
| Invested Capital | 950.40 Cr | 816.51 Cr | 713.04 Cr | 730.40 Cr | — |
| Working Capital | 230.10 Cr | 202.18 Cr | 155.74 Cr | 180.57 Cr | — |
| Net Tangible Assets | 637.51 Cr | 533.67 Cr | 459.06 Cr | 468.92 Cr | — |
| Capital Lease Obligations | 0.00 | 0.59 Cr | 1.55 Cr | 3.15 Cr | — |
| Common Stock Equity | 639.64 Cr | 536.33 Cr | 460.53 Cr | 470.29 Cr | — |
| Total Capitalization | 779.01 Cr | 658.42 Cr | 581.66 Cr | 619.79 Cr | — |
| Total Equity Gross Minority Interest | 639.64 Cr | 536.33 Cr | 460.53 Cr | 470.29 Cr | — |
| Minority Interest | 1000.00 | — | — | — | — |
| Stockholders Equity | 639.64 Cr | 536.33 Cr | 460.53 Cr | 470.29 Cr | — |
| Other Equity Interest | 630.78 Cr | 28.57 Cr | 452.06 Cr | 461.82 Cr | — |
| Capital Stock | 8.87 Cr | 8.47 Cr | 8.47 Cr | 8.47 Cr | — |
| Common Stock | 8.87 Cr | 8.47 Cr | 8.47 Cr | 8.47 Cr | — |
| Total Liabilities Net Minority Interest | 513.04 Cr | 497.76 Cr | 419.08 Cr | 389.21 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 188.67 Cr | 166.05 Cr | 164.17 Cr | 192.73 Cr | — |
| Non Current Deferred Taxes Liabilities | 48.10 Cr | 42.80 Cr | 41.02 Cr | 39.55 Cr | — |
| Long Term Debt And Capital Lease Obligation | 139.36 Cr | 122.09 Cr | 121.75 Cr | 151.62 Cr | — |
| Long Term Debt | 139.36 Cr | 122.09 Cr | 121.13 Cr | 149.50 Cr | — |
| Long Term Provisions | 1.21 Cr | 1.16 Cr | 1.40 Cr | 1.76 Cr | — |
| Current Liabilities | 324.37 Cr | 331.72 Cr | 254.91 Cr | 196.48 Cr | — |
| Other Current Liabilities | 4.59 Cr | 4.83 Cr | 1.52 Cr | 2.68 Cr | — |
| Current Debt And Capital Lease Obligation | 171.39 Cr | 158.68 Cr | 132.32 Cr | 111.65 Cr | — |
| Current Capital Lease Obligation | 0.00 | 0.59 Cr | 0.94 Cr | 1.04 Cr | — |
| Current Debt | 171.39 Cr | 158.09 Cr | 131.38 Cr | 110.61 Cr | — |
| Current Provisions | 1.11 Cr | 1.03 Cr | 1.04 Cr | 0.82 Cr | — |
| Payables | 113.92 Cr | 170.03 Cr | 120.40 Cr | 79.88 Cr | — |
| Accounts Payable | 113.92 Cr | 151.32 Cr | 107.43 Cr | 72.86 Cr | — |
| Total Assets | 1.15K Cr | 1.03K Cr | 879.61 Cr | 859.50 Cr | — |
| Total Non Current Assets | 598.21 Cr | 500.20 Cr | 468.96 Cr | 482.45 Cr | — |
| Other Non Current Assets | 8.99 Cr | 13.87 Cr | 5.61 Cr | 4.30 Cr | — |
| Investmentin Financial Assets | 21.57 Cr | 18.80 Cr | 18.14 Cr | 29.15 Cr | — |
| Available For Sale Securities | 21.57 Cr | 18.80 Cr | 18.14 Cr | 29.15 Cr | — |
| Goodwill And Other Intangible Assets | 2.13 Cr | 2.66 Cr | 1.47 Cr | 1.37 Cr | — |
| Net PPE | 565.52 Cr | 478.74 Cr | 449.35 Cr | 451.93 Cr | — |
| Gross PPE | 565.52 Cr | 668.45 Cr | 609.52 Cr | 581.54 Cr | — |
| Construction In Progress | 34.67 Cr | 44.14 Cr | 38.80 Cr | 15.30 Cr | — |
| Other Properties | 530.85 Cr | 28.29 Cr | 11.93 Cr | 13.19 Cr | — |
| Current Assets | 554.47 Cr | 533.89 Cr | 410.65 Cr | 377.05 Cr | — |
| Other Current Assets | 14.64 Cr | 22.75 Cr | 18.97 Cr | 26.05 Cr | — |
| Inventory | 284.73 Cr | 233.70 Cr | 223.50 Cr | 251.10 Cr | — |
| Taxes Receivable | 0.39 Cr | 11.06 Cr | 16.52 Cr | 15.87 Cr | — |
| Accounts Receivable | 203.23 Cr | 236.23 Cr | 148.35 Cr | 48.52 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 51.48 Cr | 36.04 Cr | 7.31 Cr | 46.58 Cr | — |
| Other Short Term Investments | 10.08 Cr | 3.44 Cr | 6.69 Cr | 0.35 Cr | — |
| Cash And Cash Equivalents | 41.40 Cr | 36.04 Cr | 7.31 Cr | 46.58 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Retained Earnings | — | 324.88 Cr | 287.65 Cr | 297.41 Cr | 247.65 Cr |
| Additional Paid In Capital | — | 71.37 Cr | 71.37 Cr | 71.37 Cr | 71.37 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 1.16 Cr | 1.40 Cr | 1.57 Cr | 1.84 Cr |
| Long Term Capital Lease Obligation | — | 0.00 | 0.61 Cr | 2.11 Cr | 3.15 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 1.03 Cr | 1.04 Cr | 1.02 Cr | 0.82 Cr |
| Other Payable | — | 18.62 Cr | 12.88 Cr | 6.94 Cr | 17.05 Cr |
| Dividends Payable | — | 0.09 Cr | 0.09 Cr | 0.08 Cr | 0.09 Cr |
| Non Current Prepaid Assets | — | 5.17 Cr | 5.08 Cr | 5.02 Cr | 3.46 Cr |
| Long Term Equity Investment | — | 10.94 Cr | 10.52 Cr | 21.53 Cr | 27.30 Cr |
| Investmentsin Associatesat Cost | — | 10.94 Cr | 10.52 Cr | 21.53 Cr | 27.30 Cr |
| Other Intangible Assets | — | 2.66 Cr | 1.47 Cr | 1.37 Cr | 1.60 Cr |
| Accumulated Depreciation | — | -189.71 Cr | -160.17 Cr | -129.61 Cr | -99.17 Cr |
| Machinery Furniture Equipment | — | 457.70 Cr | 423.80 Cr | 418.78 Cr | 413.44 Cr |
| Buildings And Improvements | — | 134.11 Cr | 130.78 Cr | 130.05 Cr | 123.28 Cr |
| Land And Improvements | — | 4.21 Cr | 4.21 Cr | 4.21 Cr | 4.21 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.09 Cr | 0.09 Cr | 0.08 Cr | 0.09 Cr |
| Prepaid Assets | — | 14.94 Cr | 13.54 Cr | 11.37 Cr | 7.78 Cr |
| Other Inventories | — | 0.67 Cr | 0.56 Cr | 0.75 Cr | 0.25 Cr |
| Finished Goods | — | 54.82 Cr | 38.38 Cr | 61.42 Cr | 44.45 Cr |
| Work In Process | — | 90.47 Cr | 105.90 Cr | 118.95 Cr | 23.41 Cr |
| Raw Materials | — | 87.74 Cr | 78.66 Cr | 69.98 Cr | 69.67 Cr |
| Other Receivables | — | 1.83 Cr | 1.34 Cr | 3.53 Cr | 1.09 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.10 Cr | -0.10 Cr | -0.10 Cr | -0.10 Cr |
| Gross Accounts Receivable | — | 236.34 Cr | 148.45 Cr | 48.62 Cr | 105.78 Cr |
| Cash Financial | — | 36.04 Cr | 7.31 Cr | 34.58 Cr | 22.92 Cr |
| Cash Equivalents | — | — | 0.07 Cr | 12.00 Cr | 17.50 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sms Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.